Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nyasha Bakare

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Vaccine|January 18, 2003
Therapeutic vaccination for future management of HIV/AIDSJulianna Lisziewicz, Nyasha Bakare, Franco Lori
Vaccine|August 3, 2010
Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)Nyasha Bakare, David Menschik, Rosemary Tiernan, et al.
Vaccine|March 10, 2005
DermaVir, a novel HIV immunisation technologyFranco Lori, Jeffrey Trocio, Nyasha Bakare, et al.
AIDS (London, England)|July 2, 2005
Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanismsFranco Lori, Andrea Foli, Antonella Groff, et al.
Trials|April 2, 2024
A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECTJingtao Gao, Mengqiu Gao, Jian Du, et al.
AIDS (London, England)|January 1, 2005
Control of viral rebound through therapeutic immunization with DermaVirJulianna Lisziewicz, Jeffrey Trocio, Jianqing Xu, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
The Journal of Investigative Dermatology|January 19, 2005
DermaVir: a novel topical vaccine for HIV/AIDSJulianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, et al.
BMC Infectious Diseases|November 22, 2022
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysisHelen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, et al.
Emerging Infectious Diseases|April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant TuberculosisLawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Vaccine|January 18, 2003
Therapeutic vaccination for future management of HIV/AIDSJulianna Lisziewicz, Nyasha Bakare, Franco Lori
Vaccine|August 3, 2010
Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)Nyasha Bakare, David Menschik, Rosemary Tiernan, et al.
Vaccine|March 10, 2005
DermaVir, a novel HIV immunisation technologyFranco Lori, Jeffrey Trocio, Nyasha Bakare, et al.
AIDS (London, England)|July 2, 2005
Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanismsFranco Lori, Andrea Foli, Antonella Groff, et al.
Trials|April 2, 2024
A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECTJingtao Gao, Mengqiu Gao, Jian Du, et al.
AIDS (London, England)|January 1, 2005
Control of viral rebound through therapeutic immunization with DermaVirJulianna Lisziewicz, Jeffrey Trocio, Jianqing Xu, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
The Journal of Investigative Dermatology|January 19, 2005
DermaVir: a novel topical vaccine for HIV/AIDSJulianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, et al.
BMC Infectious Diseases|November 22, 2022
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysisHelen Pai, Norbert Ndjeka, Lawrence Mbuagbaw, et al.
Emerging Infectious Diseases|April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant TuberculosisLawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Pageof 2